124 related articles for article (PubMed ID: 19974724)
1. Pathological Report on Case of Myelogenous Leukæmia in an Infant, aged 18 months.
Whipham TR
Proc R Soc Med; 1910; 3(Sect Study Dis Child):152-4. PubMed ID: 19974724
[No Abstract] [Full Text] [Related]
2. Additional translocation (8;21)(q22;q22) in a patient with Philadelphia-positive chronic myelogenous leukaemia in the blastic phase.
Kojima K; Yasukawa M; Ishimaru F; Dansako H; Matsuo Y; Kimura Y; Nawa Y; Hara M; Harada M
Br J Haematol; 1999 Sep; 106(3):720-2. PubMed ID: 10468864
[TBL] [Abstract][Full Text] [Related]
3. Sudden hearing loss in chronic myelogenous leukaemia implicating the hyperviscosity syndrome.
Chae SW; Cho JH; Lee JH; Kang HJ; Hwang SJ
J Laryngol Otol; 2002 Apr; 116(4):291-3. PubMed ID: 11945192
[TBL] [Abstract][Full Text] [Related]
4. Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization.
Lowsky R; Fyles G; Minden M; Lipton J; Meharchand J; Tejpar I; Zipursky A; Messner H
Br J Haematol; 1996 Apr; 93(1):163-5. PubMed ID: 8611454
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population.
Hur M; Park JY; Cho HC; Lee KM; Shin HY; Cho HI
Clin Lab Haematol; 2006 Jun; 28(3):154-9. PubMed ID: 16706930
[TBL] [Abstract][Full Text] [Related]
6. Results of induction and consolidation treatment with intermediate and high-dose cytosine arabinoside and m-Amsa of patients with poor-risk acute myelogenous leukaemia.
Peters WG; Willemze R; Colly LP
Eur J Haematol; 1988 Mar; 40(3):198-204. PubMed ID: 3162718
[TBL] [Abstract][Full Text] [Related]
7. A Massive Right Atrial Mass in Chronic Myelogenous Leukaemia: A Case Report and Literature Review.
Benjanuwattra J; Abdelnabi M; Rahman R; Jenkins LA
Eur J Case Rep Intern Med; 2022; 9(8):003499. PubMed ID: 36093304
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia.
Baer MR; Ozer H; Foon KA
Br J Haematol; 1992 Jun; 81(2):167-9. PubMed ID: 1643013
[TBL] [Abstract][Full Text] [Related]
9. Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning.
Topaly J; Fruehauf S; Ho AD; Zeller WJ
Br J Cancer; 2002 May; 86(9):1487-93. PubMed ID: 11986785
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia.
Mizuno S; Emi N; Kasai M; Ishitani A; Saito H
Br J Haematol; 2000 Oct; 111(1):280-2. PubMed ID: 11091213
[TBL] [Abstract][Full Text] [Related]
11. Myelogenous Leukæmia in an Infant, aged 18 months.
Whipham TR
Proc R Soc Med; 1910; 3(Sect Study Dis Child):92-5. PubMed ID: 19974794
[No Abstract] [Full Text] [Related]
12. Early central nervous system involvement in adults with acute non-myelogenous leukaemia.
Lister TA; Whitehouse JM; Beard ME; Paxton A; Brearley RL; Brown L; Wrigley PF; Crowther D
Br J Cancer; 1977 Apr; 35(4):479-83. PubMed ID: 265731
[TBL] [Abstract][Full Text] [Related]
13. Generation of the NUP98-HOXD13 fusion transcript by a rare translocation, t(2;11)(q31;p15), in a case of infant leukaemia.
Shimada H; Arai Y; Sekiguchi S; Ishii T; Tanitsu S; Sasaki M
Br J Haematol; 2000 Jul; 110(1):210-3. PubMed ID: 10931000
[TBL] [Abstract][Full Text] [Related]
14. Leukaemia cutis in a patient with acute myelogenous leukaemia: case report.
Ogunbiyi AO; Shokunbi WA; Fasola FA; Ogunbiyi JO
East Afr Med J; 2003 Nov; 80(11):606-8. PubMed ID: 15248683
[TBL] [Abstract][Full Text] [Related]
15. Acute myelogenous leukaemia occurring at the same time in husband and wife.
Ly B; Stavem P; Saltvedt E
Scand J Haematol; 1978 Nov; 21(5):376-8. PubMed ID: 282660
[TBL] [Abstract][Full Text] [Related]
16. Pyoderma gangrenosum coexisting with acute myelogenous leukaemia.
Krauze E; Brzezińska-Wcisło L; Kamińska-Winciorek G; Wygledowska-Kania M; Sygula E
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):589-92. PubMed ID: 16164714
[TBL] [Abstract][Full Text] [Related]
17. Juvenile chronic myelogenous leukaemia: report of a case with an unusually long period of survival.
Bahakim HM
Ann Trop Paediatr; 1987 Dec; 7(4):255-8. PubMed ID: 2449849
[TBL] [Abstract][Full Text] [Related]
18. Neutrophilic eccrine hidradenitis heralding the onset of chronic myelogenous leukaemia.
Gómez Vázquez M; Peteiro C; Toribio J
J Eur Acad Dermatol Venereol; 2003 May; 17(3):328-30. PubMed ID: 12702078
[TBL] [Abstract][Full Text] [Related]
19. Neurological manifestations of chronic myelogenous leukaemia.
Aken'Ova YA; Okunade MA; Akang EE
Afr J Med Med Sci; 1996 Dec; 25(4):397-8. PubMed ID: 9532316
[TBL] [Abstract][Full Text] [Related]
20. The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.
Vrooman LM; Neuberg DS; Stevenson KE; Asselin BL; Athale UH; Clavell L; Cole PD; Kelly KM; Larsen EC; Laverdière C; Michon B; Schorin M; Schwartz CL; Cohen HJ; Lipshultz SE; Silverman LB; Sallan SE
Eur J Cancer; 2011 Jun; 47(9):1373-9. PubMed ID: 21514146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
